BACKGROUND: Recently, genetic variants of the neuronal sortilin-related receptor with A-type repeats (SORL1, also called LR11 or sorLA) have emerged as risk factors for the development of Alzheimer's disease (AD). METHODS: In this study, SORL1 gene polymorphisms, which have been shown to be related to AD, were analyzed for associations with cerebrospinal fluid (CSF) amyloid beta1-42 (Aβ(1-42)), phosphorylated tau181, and total tau levels in a non-Hispanic Caucasian sample, which encompassed 100 cognitively healthy elderly individuals, 166 patients with mild cognitive impairment, and 87 patients with probable AD. The data were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (www.loni.ucla.edu/ADNI). Moreover, the impact of gene-gene interactions between SORL1 single nucleotide polymorphisms (SNPs) and the apolipoprotein E (APOE) ε4 allele, the major genetic risk factor for sporadic AD, on Aβ(1-42) concentrations was investigated. RESULTS: Significant associations between CSF Aβ(1-42) levels and the SORL1 SNPs 23 (rs3824968) and 24 (rs2282649) were detected in the AD group. The latter association became marginally statistically insignificant after Bonferroni correction for multiple comparisons. Carriers of the SORL1 SNP24 T allele and the SNP23 A allele both had lower CSF Aβ(1-42) concentrations than non-carriers of these alleles. The analysis of the impact of interactions between APOE ε4 allele and SORL1 SNPs on CSF Aβ(1-42) levels unraveled significant influences of APOE. CONCLUSIONS: Our findings provide further support for the notion that SORL1 genetic variants are related to AD pathology, probably by regulating the amyloid cascade.
BACKGROUND: Recently, genetic variants of the neuronal sortilin-related receptor with A-type repeats (SORL1, also called LR11 or sorLA) have emerged as risk factors for the development of Alzheimer's disease (AD). METHODS: In this study, SORL1 gene polymorphisms, which have been shown to be related to AD, were analyzed for associations with cerebrospinal fluid (CSF) amyloid beta1-42 (Aβ(1-42)), phosphorylated tau181, and total tau levels in a non-Hispanic Caucasian sample, which encompassed 100 cognitively healthy elderly individuals, 166 patients with mild cognitive impairment, and 87 patients with probable AD. The data were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (www.loni.ucla.edu/ADNI). Moreover, the impact of gene-gene interactions between SORL1 single nucleotide polymorphisms (SNPs) and the apolipoprotein E (APOE) ε4 allele, the major genetic risk factor for sporadic AD, on Aβ(1-42) concentrations was investigated. RESULTS: Significant associations between CSF Aβ(1-42) levels and the SORL1 SNPs 23 (rs3824968) and 24 (rs2282649) were detected in the AD group. The latter association became marginally statistically insignificant after Bonferroni correction for multiple comparisons. Carriers of the SORL1 SNP24 T allele and the SNP23 A allele both had lower CSF Aβ(1-42) concentrations than non-carriers of these alleles. The analysis of the impact of interactions between APOE ε4 allele and SORL1 SNPs on CSF Aβ(1-42) levels unraveled significant influences of APOE. CONCLUSIONS: Our findings provide further support for the notion that SORL1 genetic variants are related to AD pathology, probably by regulating the amyloid cascade.
Authors: Tanja Richter-Schmidinger; Panagiotis Alexopoulos; Marco Horn; Sebastian Maus; Martin Reichel; Cosima Rhein; Piotr Lewczuk; Christos Sidiropoulos; Thomas Kneib; Robert Perneczky; Arnd Doerfler; Johannes Kornhuber Journal: J Neural Transm (Vienna) Date: 2010-12-29 Impact factor: 3.575
Authors: John S K Kauwe; Jun Wang; Kevin Mayo; John C Morris; Anne M Fagan; David M Holtzman; Alison M Goate Journal: Neurogenetics Date: 2008-09-24 Impact factor: 2.660
Authors: Heike Kölsch; Frank Jessen; Jens Wiltfang; Piotr Lewczuk; Martin Dichgans; Johannes Kornhuber; Lutz Frölich; Isabella Heuser; Oliver Peters; Jörg B Schulz; Sibylle G Schwab; Wolfgang Maier Journal: Neurosci Lett Date: 2008-05-18 Impact factor: 3.046
Authors: Fan Liu; M Arfan Ikram; A Cecile J W Janssens; Maaike Schuur; Inge de Koning; Aaron Isaacs; Maksim Struchalin; Andre G Uitterlinden; Johan T den Dunnen; Kristel Sleegers; Karolien Bettens; Christine Van Broeckhoven; John van Swieten; Albert Hofman; Ben A Oostra; Yurii S Aulchenko; Monique M B Breteler; Cornelia M van Duijn Journal: J Alzheimers Dis Date: 2009 Impact factor: 4.472
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2015-06 Impact factor: 21.566
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Li Shen; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2013-08-07 Impact factor: 21.566
Authors: Lyzel S Elias-Sonnenschein; Seppo Helisalmi; Teemu Natunen; Anette Hall; Teemu Paajanen; Sanna-Kaisa Herukka; Marjo Laitinen; Anne M Remes; Anne M Koivisto; Kari M Mattila; Terho Lehtimäki; Frans R J Verhey; Pieter Jelle Visser; Hilkka Soininen; Mikko Hiltunen Journal: PLoS One Date: 2013-04-03 Impact factor: 3.240